ResearcherUniversity of IowaNo recent work listed
Jessemae L. Welsh
Matched on OpenAlex author ID A5059087783. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper
Papers 4
- Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-14-1707↗
- Extracellular superoxide dismutase suppresses hypoxia-inducible factor-1α in pancreatic cancer. First author DOI 10.1016/j.freeradbiomed.2014.02.002↗
- Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Co-author DOI 10.1007/s00280-013-2070-8↗
- Comparison of response evaluation criteria in solid tumors with volumetric measurements for estimation of tumor burden in pancreatic adenocarcinoma and hepatoc… Co-author DOI 10.1016/j.amjsurg.2012.07.007↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Joseph J. Cullen · 4 shared papers, 2012–2015 · strength 0.15
- Paper Extracellular superoxide dismutase suppresses hypoxia-inducible factor-1α in pancreatic cancer. DOI 10.1016/j.freeradbiomed.2014.02.002↗
- Paper Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer. DOI 10.1158/0008-5472.can-14-1707↗
- Paper Comparison of response evaluation criteria in solid tumors with volumetric measurements for estimation of tumor burden … DOI 10.1016/j.amjsurg.2012.07.007↗
- Garry R. Buettner · 3 shared papers, 2013–2015 · strength 0.11
- Paper Extracellular superoxide dismutase suppresses hypoxia-inducible factor-1α in pancreatic cancer. DOI 10.1016/j.freeradbiomed.2014.02.002↗
- Paper Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer. DOI 10.1158/0008-5472.can-14-1707↗
- Paper Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): … DOI 10.1007/s00280-013-2070-8↗
- Juan Du · 3 shared papers, 2013–2015 · strength 0.11
- Paper Extracellular superoxide dismutase suppresses hypoxia-inducible factor-1α in pancreatic cancer. DOI 10.1016/j.freeradbiomed.2014.02.002↗
- Paper Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer. DOI 10.1158/0008-5472.can-14-1707↗
- Paper Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): … DOI 10.1007/s00280-013-2070-8↗
- Prabhat C. Goswami · 2 shared papers, 2014–2015 · strength 0.08
- John A. Cieslak · 2 shared papers, 2014–2015 · strength 0.08
- Zita A. Sibenaller · 2 shared papers, 2014–2015 · strength 0.08
- Kellie L. Bodeker · 2 shared papers, 2012–2013 · strength 0.07
- Paper Comparison of response evaluation criteria in solid tumors with volumetric measurements for estimation of tumor burden … DOI 10.1016/j.amjsurg.2012.07.007↗
- Paper Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): … DOI 10.1007/s00280-013-2070-8↗
- Douglas Robert Spitz · 1 shared paper, 2015 · strength 0.04
- James J. Mezhir · 1 shared paper, 2015 · strength 0.04
- Bryan G. Allen · 1 shared paper, 2015 · strength 0.04
- Susan Tsai · 1 shared paper, 2015 · strength 0.04
- John Michael Buatti · 1 shared paper, 2012 · strength 0.04
- Daniel Berg · 1 shared paper, 2013 · strength 0.03
- Mark Levine · 1 shared paper, 2013 · strength 0.03
- Thorvardur Ragnar Halfdanarson · 1 shared paper, 2013 · strength 0.03
- Jeanne Drisko · 1 shared paper, 2013 · strength 0.03
- Nelson S. Yee · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.